Integrated analysis of multimodal single-cell data Y Hao, S Hao, E Andersen-Nissen, WM Mauck, S Zheng, A Butler, MJ Lee, ... Cell 184 (13), 3573-3587. e29, 2021 | 7306 | 2021 |
Orchestrating high-throughput genomic analysis with Bioconductor W Huber, VJ Carey, R Gentleman, S Anders, M Carlson, BS Carvalho, ... Nature methods 12 (2), 115-121, 2015 | 3450 | 2015 |
MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data G Finak, A McDavid, M Yajima, J Deng, V Gersuk, AK Shalek, CK Slichter, ... Genome biology 16, 1-13, 2015 | 2387 | 2015 |
Multiple early factors anticipate post-acute COVID-19 sequelae Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ... Cell 185 (5), 881-895. e20, 2022 | 825 | 2022 |
Critical assessment of automated flow cytometry data analysis techniques N Aghaeepour, G Finak, FlowCAP Consortium, Dream Consortium, ... Nature methods 10 (3), 228-238, 2013 | 655 | 2013 |
Orchestrating single-cell analysis with Bioconductor RA Amezquita, ATL Lun, E Becht, VJ Carey, LN Carpp, L Geistlinger, ... Nature methods 17 (2), 137-145, 2020 | 635 | 2020 |
Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions L Vojtech, S Woo, S Hughes, C Levy, L Ballweber, RP Sauteraud, J Strobl, ... Nucleic acids research 42 (11), 7290-7304, 2014 | 573 | 2014 |
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial M Alberer, U Gnad-Vogt, HS Hong, KT Mehr, L Backert, G Finak, ... The Lancet 390 (10101), 1511-1520, 2017 | 503 | 2017 |
Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19 Y Su, D Chen, D Yuan, C Lausted, J Choi, CL Dai, V Voillet, VR Duvvuri, ... Cell 183 (6), 1479-1495. e20, 2020 | 502 | 2020 |
Model-based analysis of tiling-arrays for ChIP-chip WE Johnson, W Li, CA Meyer, R Gottardo, JS Carroll, M Brown, XS Liu Proceedings of the National Academy of Sciences 103 (33), 12457-12462, 2006 | 500 | 2006 |
Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function AI Salter, RG Ivey, JJ Kennedy, V Voillet, A Rajan, EJ Alderman, ... Science signaling 11 (544), eaat6753, 2018 | 410 | 2018 |
Data exploration, quality control and testing in single-cell qPCR-based gene expression experiments A McDavid, G Finak, PK Chattopadyay, M Dominguez, L Lamoreaux, ... Bioinformatics 29 (4), 461-467, 2013 | 400 | 2013 |
Spatial transcriptomics at subspot resolution with BayesSpace E Zhao, MR Stone, X Ren, J Guenthoer, KS Smythe, T Pulliam, ... Nature biotechnology 39 (11), 1375-1384, 2021 | 384 | 2021 |
Combining mixture components for clustering JP Baudry, AE Raftery, G Celeux, K Lo, R Gottardo Journal of computational and graphical statistics 19 (2), 332-353, 2010 | 380 | 2010 |
Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies A deCamp, P Hraber, RT Bailer, MS Seaman, C Ochsenbauer, J Kappes, ... Journal of virology 88 (5), 2489-2507, 2014 | 332 | 2014 |
Automated gating of flow cytometry data via robust model‐based clustering K Lo, RR Brinkman, R Gottardo Cytometry Part A: the journal of the International Society for Analytical …, 2008 | 319 | 2008 |
Standardizing flow cytometry immunophenotyping analysis from the human immunophenotyping consortium G Finak, M Langweiler, M Jaimes, M Malek, J Taghiyar, Y Korin, ... Scientific reports 6 (1), 1-11, 2016 | 298 | 2016 |
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant AG Chapuis, DN Egan, M Bar, TM Schmitt, MS McAfee, KG Paulson, ... Nature medicine 25 (7), 1064-1072, 2019 | 279 | 2019 |
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial R Gottardo, RT Bailer, BT Korber, S Gnanakaran, J Phillips, X Shen, ... PloS one 8 (9), e75665, 2013 | 258 | 2013 |
The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120 N Karasavvas, E Billings, M Rao, C Williams, S Zolla-Pazner, RT Bailer, ... AIDS research and human retroviruses 28 (11), 1444-1457, 2012 | 247 | 2012 |